The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey: Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias

Vincenzo De Sanctis; Ashraf  Soliman; Ploutarchos   Tzoulis; Shahina   Daar; Antonis   Kattamis; Polyxeni  Delaporta; Mohamed A.   Yassin; Mehran   Karimi; Duran   Canatan; Soad  Al Jaouni; Maria Concetta   Galati; Giuseppe   Raiola; Giuseppe   Messina; Saveria   Campisi; Forough  Saki; Dulani   Kottahachchi; Valeria   Kaleva; Kristina   Petrova; Atanas   Banchev; Christos   Kattamis

doi:10.23750/abm.v92i3.11733

The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey

Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias

Authors

Vincenzo De Sanctis Quisisana Hospital, Ferrara
Ashraf Soliman Department of Pediatrics, Division of Endocrinology, Hamad General Hospital, Doha, Qatar and Department of Pediatrics, Division of Endocrinology, Alexandria University Children’s Hospital, Alexandria, Egypt
Ploutarchos Tzoulis Department of Diabetes and Endocrinology, Whittington Hospital, University College London, London, UK
Shahina Daar Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman
Antonis Kattamis Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece
Polyxeni Delaporta Thalassemia Unit, Division of Pediatric Hematology-Oncology, First Department of Pediatrics, University of Athens, "Agia Sofia" Children's Hospital, Athens, Greece
Mohamed A. Yassin National Center for Cancer Care and Research, Medical Oncology Hematology Section HMC, Doha, Qatar
Mehran Karimi Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Duran Canatan Medical Director of Antalya Genetic Diseases Center, Antalya, Turkey
Soad Al Jaouni Head Division of Pediatric Hematology Oncology, Department of Hematology Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
Maria Concetta Galati Department of Pediatric Haematoncology, Thalassaemia and Prenatal Diagnosis Regional Center, Pugliese-Ciaccio Hospital, Catanzaro, Italy
Giuseppe Raiola Department of Paediatrics, Pugliese-Ciaccio Hospital,Catanzaro, Italy
Giuseppe Messina UOSD Microcitemie, Grande Ospedale Metropolitano “Bianchi- Melacrino- Morelli”, Reggio Calabria, Italy
Saveria Campisi UOSD Thalassemia, Umberto I° Hospital, Siracusa, Italy
Forough Saki Shiraz Endocrinology and Metabolism Research Center, Shiraz, Iran
Dulani Kottahachchi Thalassaemia Care Unit, Colombo North Teaching Hospital, Sri Lanka
Valeria Kaleva Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria
Kristina Petrova Varna Expert Center for Coagulopathies and Rare Anemias, Sofia, Bulgaria
Atanas Banchev Pediatric Hematology-Oncology, University Hospital "Tzaritza Giovanna - ISUL", Sofia, Bulgaria
Christos Kattamis First Department of Paediatrics, National Kapodistrian University of Athens, Greece

DOI: https://doi.org/10.23750/abm.v92i3.11733

Keywords:

Thalassemias, prevalence, glucose dysregulations

Abstract

.

References

De Sanctis V, Soliman A,Tzoulis P, et al. Early detection of glucose dysregulation (GD) in patients with β-thalassemia major: Review of current diagnostic criteria and the ICET-A survey. Curr Trends Endocrinol. 2021;11:1-11.

He LN, Chen W, Yang Y, et al. Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis. Biomed Res Int 2019;2019:6573497.

Farmaki K, Angelopoulos N, Anagnostopoulos G, et al. Effect of enhanced iron chelation therapy on glucose metabolism in patients with b-thalassaemia major. Br J Hematol. 2006;134:438-444.

Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A. Guidelines for diagnosis and management of Beta-thalassemia intermedia. Pediatr Hematol Oncol. 2014;31:583-96.

De Sanctis V, Soliman AT. ICET-A an Opportunity for Improving Thalassemia Management. J Blood Disord. 2014;1: 1-2.

Chuncharunee S, Teawtrakul N, Siritanaratkul N, Chueamuangphan N. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. PLoS One 2019;14:e0214148.